Literature DB >> 20595523

Uncommon BCR-ABL kinase domain mutations in kinase inhibitor-resistant chronic myelogenous leukemia and Ph+ acute lymphoblastic leukemia show high rates of regression, suggesting weak selective effects.

Dan Jones, Su S Chen, Elias Jabbour, Mary Beth Rios, Hagop Kantarjian, Jorge Cortes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20595523     DOI： 10.1182/blood-2009-11-252155

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  Migrating to Long-Read Sequencing for Clinical Routine BCR-ABL1 TKI Resistance Mutation Screening.

Authors:  Wesley Schaal; Adam Ameur; Ulla Olsson-Strömberg; Monica Hermanson; Lucia Cavelier; Ola Spjuth
Journal:  Cancer Inform       Date:  2022-07-15

2.  Integrated genomic sequencing in myeloid blast crisis chronic myeloid leukemia (MBC-CML), identified potentially important findings in the context of leukemogenesis model.

Authors:  Golnaz Ensieh Kazemi-Sefat; Mohammad Keramatipour; Mohammad Vaezi; Seyed Mohsen Razavi; Kaveh Kavousi; Amin Talebi; Shahrbanoo Rostami; Marjan Yaghmaei; Bahram Chahardouli; Saeed Talebi; Kazem Mousavizadeh
Journal:  Sci Rep       Date:  2022-07-27       Impact factor: 4.996

Review 3.  Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Kathrin M Bernt; Stephen P Hunger
Journal:  Front Oncol       Date:  2014-03-25       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.